Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

18.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 70.00p
  • 52 Week Low: 12.00p
  • Currency: UK Pounds
  • Shares Issued: 92.53m
  • Volume: 354,578
  • Market Cap: 17.12m
  • RiskGrade: 747

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-21 Interim n/a (2.81) (3.00)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 2.62 (7.58) (35.36)p n/a n/a n/a n/a 0.0%
30-Jun-18 1.94 (7.79) (37.24)p n/a n/a n/a n/a 0.0%
30-Jun-19 2.36 (4.52) (13.87)p n/a n/a n/a n/a 0.0%
30-Jun-20 1.06 (20.38) (54.48)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.69 (1.85) (1.19)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 n/a n/a n/a n/a n/a n/a n/a 0.0%
30-Jun-23 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genedrive Market Data

Currency UK Pounds
Share Price 18.50p
Change Today -1.00p
% Change -5.13 %
52 Week High 70.00p
52 Week Low 12.00p
Volume 354,578
Shares Issued 92.53m
Market Cap 17.12m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.99% below the market average34.99% below the market average34.99% below the market average34.99% below the market average34.99% below the market average
52.63% below the sector average52.63% below the sector average52.63% below the sector average52.63% below the sector average52.63% below the sector average
Price Trend
91.38% below the market average91.38% below the market average91.38% below the market average91.38% below the market average91.38% below the market average
79.49% below the sector average79.49% below the sector average79.49% below the sector average79.49% below the sector average79.49% below the sector average
Income Not Available
Growth
60.96% below the market average60.96% below the market average60.96% below the market average60.96% below the market average60.96% below the market average
82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average82.86% below the sector average

Genedrive Dividends

No dividends found

Trades for 27-Jun-2022

Time Volume / Share Price
15:27 367 @ 18.27p
14:57 26,781 @ 18.67p
14:46 2,475 @ 18.27p
13:11 4,659 @ 18.23p
12:41 9,408 @ 18.27p

Genedrive Key Personnel

CEO David Budd
CFO Russell Shaw

Top of Page